tiprankstipranks
Trending News
More News >
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE

Ultragenyx Pharmaceutical (RARE) Revenue

Compare
1,087 Followers

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical had a revenue of 159.93M in the quarter ending Sep 30, 2025, with -3.94%. This bring the company's revenue in the last twelve months to 630.60M, Decreased 3.35%. In the fiscal year ending Dec 31, 2024, Ultragenyx Pharmaceutical had annual revenue of 560.23M with 29.01% growth.
Revenue (ttm)
630.60M
Revenue Growth
20.63%
P/S Ratio
6.24
Revenue/Employee
$432,944
Employees
1,294
Market Cap
$3.50B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
560.23M125.98M+129.01%
Dec 31, 2023
434.25M70.92M+119.52%
Dec 31, 2022
363.33M11.92M+103.39%
Dec 31, 2021
351.41M80.38M+129.66%
Dec 31, 2020
271.03M167.32M+261.32%
Dec 31, 2019
103.71M52.22M+201.41%
Dec 31, 2018
51.49M48.88M+1,971.48%
Dec 31, 2017
2.61M2.48M+1,963.92%
Dec 31, 2016
133.00K